| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8236136 | International Journal of Radiation Oncology*Biology*Physics | 2009 | 5 Pages |
Abstract
IMRT confers only a marginal benefit in the adjuvant treatment of gastric cancer and should be used only in the small subset of patients with risk factors for kidney disease or those with a preexisting nephropathy.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Shlomo B.Sc., Viacheslav M.D., Natan B.Sc., Dan M.Sc., Benjamin W. M.D.,